Global Microarray Analysis Market—Forecast till 2027

Global Microarray Analysis Market—Forecast till 2027

$4450 – $6250

The global microarray analysis market is anticipated to reach USD 6,607.64 million by 2027 to witness a healthy  CAGR of 7.76%.

SKU: MRFR210197 Category: Tags: , , , , ,

Description

Global Microarray Analysis Market

By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

Market Review
The microarray analysis market is anticipated to reach USD 6,607.64 million by 2027 to witness a healthy CAGR of 7.76%. Microarray is an incredible methodology used to examine quality articulation for different trial purposes. Various microarray stages are accessible for testing. The advancement of microarrays had worked on the aftereffects of hereditary testing.

The worldwide microarrays investigation market is significantly determined by the high pervasiveness of malignancy and the rising requirement for research in drug enterprises. However, the Presence of substitutes and lack of skilled professionals are expected to restrain the global market growth during the review period.

The expanding commonness of various ongoing sicknesses, utilization of this procedure to analyze irresistible illnesses, improvement in the field of hereditary qualities, and expanding medical care consumption have given a push to the market.

The growth of the global market is attributed to the increasing application area of microarrays, the increasing prevalence of cancer, and Funding for genomic and proteomic research. Nevertheless, the significant expense of tests and the requirement for innovative instruments might control the development of the microarray investigation market.

Market Segmentation
The global Microarrays market has been classified into Product & Services, type, and application.
In terms of products and services, the global market has been divided into Consumables, Software and Services, and Instruments.
By Type segment, the global market is categorized into DNA Microarrays, Protein Microarrays, and others.
Based on Application the market has been classified into Drug Discovery, Disease Diagnostics, Research Applications, and Others

Global Microarray Analysis Market, based on End User has been classified into Research Academic Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others

Regional Analysis
The global microarray analysis market, in terms of region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
In 2019, the Americas represented the biggest portion of the overall industry of 40.98% and were assessed to overwhelm the worldwide microarray investigation market all through the estimated time frame.

This biggest portion of the overall industry can be credited to the expanding reception of new advances and the presence of a key part in the district. The Americas is additionally ordered into North America and Latin America.

Europe holds a sound offer in the worldwide microarray examination market and is the second-biggest market after the Americas, attributable to the exceptionally created medical care industry, conspicuous exploration and improvement framework, and availability of items.

The microarray investigation market in Asia-Pacific is divided into China, Japan, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. This territorial market is expected to be the second quickest developing market.

Major players
The major Companies Covered in Microarray Analysis Market Report are Agilent Technologies (US), Bio-Rad Laboratories (US), Illumina (US), Thermo Fisher Scientific (US), Microarrays, Inc. (US), PerkinElmer, Inc. (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), and Arrayit Corporation (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 2.5 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 GROWING APPLICATION AREAS OF MICROARRAYS 4.2.2 INCREASING INCIDENCE OF CANCER 4.2.3 FUNDING FOR GENOMIC AND PROTEOMIC RESEARCH 4.3 RESTRAINTS 4.3.1 PRESENCE OF SUBSTITUTES AND LACK OF SKILLED PROFESSIONALS 4.4 OPPORTUNITIES 4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING MARKETS 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION AND SALES 5.1.4 POST-SALES MONITORING 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF SUPPLIERS 5.2.2 BARGAINING POWER OF BUYERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON THE MICROARRAY ANALYSIS MARKET 5.3.1 OVERVIEW 5.3.2 IMPACT ON SUPPLY CHAIN 5.3.3 IMPACT ON DEVELOPMENT OF NEW MICROARRAY PRODUCTS FOR MAPPING COVID-19 6 GLOBAL MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES 6.1 OVERVIEW 6.2 CONSUMABLES 6.3 SOFTWARE AND SERVICES 6.4 INSTRUMENTS 7 GLOBAL MICROARRAY ANALYSIS MARKET, BY TYPE 7.1 OVERVIEW 7.2 DNA MICROARRAYS 7.3 PROTEIN MICROARRAYS 7.4 OTHERS 8 GLOBAL MICROARRAY ANALYSIS MARKET, BY APPLICATION 8.1 OVERVIEW 8.2 DRUG DISCOVERY 8.3 DISEASE DIAGNOSTICS 8.4 RESEARCH APPLICATIONS 8.5 OTHERS 9 GLOBAL MICROARRAY ANALYSIS MARKET, BY END USERS 9.1 OVERVIEW 9.2 RESEARCH & ACADEMIC INSTITUTES 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 9.4 DIAGNOSTIC LABORATORIES 9.5 OTHERS 10 GLOBAL MICROARRAY ANALYSIS MARKET, BY REGION 10.1 OVERVIEW 10.2 AMERICAS 10.2.1 NORTH AMERICA 10.2.1.1 U.S. 10.2.1.2 CANADA 10.2.2 LATIN AMERICA 10.3 EUROPE 10.3.1 WESTERN EUROPE 10.3.1.1 GERMANY 10.3.1.2 FRANCE 10.3.1.3 UK 10.3.1.4 ITALY 10.3.1.5 SPAIN 10.3.1.6 REST OF WESTERN EUROPE 10.3.2 EASTERN EUROPE 10.4 ASIA-PACIFIC 10.4.1 CHINA 10.4.2 INDIA 10.4.3 JAPAN 10.4.4 SOUTH KOREA 10.4.5 AUSTRALIA 10.4.6 REST OF ASIA-PACIFIC 10.5 MIDDLE EAST & AFRICA 10.5.1 MIDDLE EAST 10.5.2 AFRICA 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 11.2 MARKET SHARE ANALYSIS 11.3 COMPETITIVE BENCHMARKING 11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROARRAY ANALYSIS MARKET 11.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICROARRAY MARKET 11.6 KEY DEVELOPMENT ANALYSIS 11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS 11.7.2 PARTNERSHIPS/AGREEMENTS 11.7.3 ACQUISITIONS 11.7.4 EXPANSIONS 12 COMPANY PROFILES 12.1 THERMO FISHER SCIENTIFIC INC. 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 PRODUCTS/SERVICES OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 AGILENT TECHNOLOGIES 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS/SERVICES OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 SWOT ANALYSIS 12.2.6 KEY STRATEGIES 12.3 ILLUMINA 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCTS/SERVICES OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 SWOT ANALYSIS 12.3.6 KEY STRATEGIES 12.4 PERKINELMER, INC 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS/SERVICES OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 SWOT ANALYSIS 12.4.6 KEY STRATEGIES 12.5 MERCK KGAA 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS/SERVICES OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 SWOT ANALYSIS 12.5.6 KEY STRATEGIES 12.6 GE HEALTHCARE 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS/SERVICES OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 SWOT ANALYSIS 12.6.6 KEY STRATEGIES 12.7 DANAHER CORPORATION 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS/SERVICES OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 SWOT ANALYSIS 12.7.6 KEY STRATEGIES 12.8 ARRAYIT CORPORATION 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS/SERVICES OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 SWOT ANALYSIS 12.8.6 KEY STRATEGIES 12.9 BIO-RAD LABORATORIES 12.9.1 COMPANY OVERVIEW 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS/SERVICES OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 SWOT ANALYSIS 12.9.6 KEY STRATEGIES 12.10 MICROARRAYS INC. 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS/SERVICES OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 SWOT ANALYSIS 12.10.6 KEY STRATEGIES 13 APPENDIX 13.1 REFERENCES 13.2 RELATED REPORTS

Related products